Quiz

Prostate Cancer

Prostate Cancer CME Series: Treatment Across the Prostate Cancer Continuum for Primary Care Clinicians

Name: Treatment Across the Prostate Cancer Continuum for Primary Care
Uploaded: 8/25/2022
Duration: T1H58M30S
Description: This is a recorded presentation of the Prostate Cancer CME Series. The goal of the series is to enhance understanding of increasingly complex treatment options and close knowledge gaps in earlier stages of prostate cancer.

Learning Objectives
1. Identify the different prostate cancer disease states in the castration-sensitive prostate cancer (CSPC) setting
2. Navigate the lack of consensus in how to care for patients with prostate cancer in early stages of disease
3. Explain the historical landscape of testing and screening in prostate cancer
4. Describe the implications of health disparities in prostate cancer screening and treatment

2 Credits CME

Stanford Medicine

Activity Information and Disclosures

Published Online: August 25, 2022 Video 1 hr 58 min 30 sec

Watch Take Quiz Resources

Internet Enduring Material sponsored and presented by the Center for Continuing Medical Education at the Stanford School of Medicine. This is a recorded presentation of the Prostate Cancer CME Series: Treatment Across the Prostate Cancer Continuum for Primary Care Clinicians held on Monday, March 21, 2022. The goal of the series is to enhance understanding of increasingly complex treatment options and close knowledge gaps in earlier stages of prostate cancer. This session was targeted towards the primary care clinicians and included a discussion on the historical landscape of testing, blood based diagnostic biomarkers and screening, the latest in diagnostics, role of genetics and genomics and highlight existing disparities in prostate cancer.

Take Quiz

Resources

References: Prostate Cancer CME Series – Primary Care Clinicians' Track

Video Information

All Rights Reserved. The content of this activity is protected by U.S. and International copyright laws. Reproduction and distribution of its content without written permission of its creator(s) is prohibited.

This CME activity is supported by an educational grant from Astellas Pharma Global Development, Inc. and its collaborative partner, Pfizer, Inc.

Financial Support Disclosure Statement: Stanford Medicine adheres to the Standards for Integrity and Independence in Accredited Continuing Education.

There are no relevant financial relationships with ACCME-defined ineligible companies for anyone who was in control of the content of this activity, except those listed in the below table. All of the relevant financial relationships listed for these individuals have been mitigated.

Ali R Khaki, MD

Clinical Assistant Professor

Stanford Health Care (SHC)

Co-Course Director, Faculty

Stocks or stock options, excluding diversified mutual funds-Merck and Company, Inc. (Relationship has ended)|Stocks or stock options, excluding diversified mutual funds-Sanofi-Aventis (Relationship has ended)|Stocks or stock options, excluding diversified mutual funds-Doximity (Relationship has ended)

Hala Borno, MD

Assistant Professor, Medicine

UCSF

Faculty

Paid consultant-AstraZeneca (Relationship has ended)|Executive-Trial Libray, Inc

Matthew R Cooperberg, MD, MPH

Professor of Urology; Epidemiology & Biostatistics

UCSF

Faculty

John Leppert, MD, MS

Professor

Stanford University

Faculty

Nothing to disclose

Sumit Anil Shah, MD

Stanford

Faculty

Advisor-Natera|Grant or research support-Genentech, Inc.

Geoffrey Alexander Sonn, MD

Assistant Professor of Urology

Stanford Health Care (SHC)

Faculty

Nothing to disclose

Ruth Adewuya, MD, CHCP

Managing Director, CME

Stanford University School of Medicine

Planner

Nothing to disclose

Laura Ruffo, NP

Stanford Health Care (SHC)

Planner

Nothing to disclose

Accreditation
In support of improving patient care, Stanford Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation
Stanford Medicine designates this Enduring Material for a maximum of 2.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Prostate Cancer CME Series: Treatment Across the Prostate Cancer Continuum for Primary Care Clinicians

Resources

Prostate Cancer CME Series: Treatment Across the Prostate Cancer Continuum - Specialists Track

AMA Membership provides:

Sign in to access

Sign in to customize your interests

Name Your Search

Sign in to save your search

Lookup An Activity

My Saved Searches

My Saved Courses

Purchase access